CONFERENCE COVERAGE SERIES
International Conference on Alzheimer's Disease 2004
Philadelphia, Pennsylvania, U.S.A.
20 – 25 July 2004
Philadelphia: All Eyes on PIB Imaging—Is It Coming Along?
Brain imaging has emerged as perhaps the most promising source to date of an antecedent marker for Alzheimer's disease...
Philadelphia: All Is Not Well with the Statin Story
One of the field’s biggest hopes for a quick and easy new AD therapy received a punch in the stomach today...
Philadelphia: Can a Shrinking Brain Be Good for You?
Perhaps…yes? At first blush, this is the tentative conclusion one must draw if the results of presentations yesterday on Elan's vaccine...
Philadelphia: Dementia Types Just Won’t Fit into Little Boxes
APP and presenilin mutations cause Alzheimer’s, tau mutations cause tauopathies, and α-synuclein mutations cause Parkinson’s, right? Well, yes, but...
Philadelphia: Diagnosis Light—Toward Infrared Plaques
If you’ve ever shone a flashlight through your hand and noticed what comes out on the other side, you have seen for yourself why red light could, in theory, make a medium for live diagnostics...
Philadelphia: European Trial of Alzhemed Ends, Marketing Morphs to Supplement
Neurochem announced last week that it would halt development of tramiprosate (Alzhemed)...
Philadelphia: Mom Was Right. Eat Your Carrots!
At the Philadelphia conference, Francine Grodstein presented data demonstrating that taking β-carotene starting in late mid-life protects...
Philadelphia: Targets in a Barely Tapped Market Keep Big Pharma Focused on AD
At the l7th Annual Marian S. Ware Neurodegenerative Diseases Research Retreat, hosts Virginia Lee and John Trojanowski pulled together a formidable roster of speakers...
Philadelphia: The Enemy Within—Neurodegeneration From Intraneuronal Aβ
One of the basic research flavors that wafted pungently through the 9th International Conference on Alzheimer’s Disease and Related Disorders is the growing sense that intraneuronal Aβ may...